
COMP360 Psilocybin for Treatment-Resistant Depression If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before X 1, Y then the market resolves to Yes. Early close condition: This market will close and expire early if the event occurs. This market will close and expire early if the event occurs.
55%
$0.00
3

55%
$0.00
3
3 markets tracked
No data available
| Market | Price |
|---|---|
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before 2028) | 55% |
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before October 2027) | 43% |
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? (Before July 2027) | 20% |